Investment Thesis
Core Scientific exhibits severe financial distress with negative stockholders' equity of -$962.7M, indicating liabilities exceed assets and shareholder value has been destroyed. The company burns through capital with negative free cash flow of -$450.8M despite generating $278.2M in operating cash flow, driven by unsustainable capital expenditures of $729M. Revenue declined 37.5% YoY while net losses widened to -$288.6M, demonstrating deteriorating operational performance across all profitability metrics.
Strengths
- Operating cash flow of $278.2M provides near-term liquidity buffer
- Current ratio of 1.15x indicates ability to cover short-term obligations
- Cash position of $311.4M offers runway for operations
Risks
- Negative stockholders' equity of -$962.7M indicates potential insolvency; liabilities ($3.3B) far exceed assets ($2.3B)
- Massive negative free cash flow of -$450.8M is unsustainable; company burning $1.41 in cash for every dollar of revenue
- Revenue collapsed 37.5% YoY while operating losses expanded to -$245.6M, indicating operational model failure and deteriorating unit economics
- Capital expenditure of $729M is grossly disproportionate to revenue base, suggesting failed growth investments or impaired asset valuations
- Net margin of -90.5% and operating margin of -77.0% demonstrate fundamental business model dysfunction
Key Metrics to Watch
- Operating cash flow trajectory and sustainability of $278.2M burn rate
- Cash depletion rate given negative FCF and current cash position of $311.4M
- Revenue stabilization and margin recovery toward positive operating income
- Capital expenditure reduction and asset utilization efficiency
- Debt restructuring or recapitalization necessity given negative equity position
Financial Metrics
Revenue
319.0M
Net Income
-288.6M
EPS (Diluted)
$-0.88
Free Cash Flow
-450.8M
Total Assets
2.3B
Cash
311.4M
Profitability Ratios
Gross Margin
11.9%
Operating Margin
-77.0%
Net Margin
-90.5%
ROE
N/A
ROA
-12.3%
FCF Margin
-141.3%
Balance Sheet & Liquidity
Current Ratio
1.15x
Quick Ratio
1.15x
Debt/Equity
N/A
Debt/Assets
141.0%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-22T20:18:11.586275 |
Data as of: 2025-12-31 |
Powered by Claude AI